ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,650Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 191

$1.12M Total Retail Price of All Prescriptions

Rank: 4 out of 191

673 Patients Receiving at Least One Drug in Part D
26%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 673 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

7% of this provider’s 2,289 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$96 was the average price of a prescription from this provider, compared to $140 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
ZOLPIDEM TARTRATE 795 205 1 7
AMPHETAMINE SALT COMBO 792 71 S2 10 2 27
TRAZODONE HCL 707 127 3 1
CARISOPRODOL 491 36 R 4 49
CYMBALTA 481 91 5 9
FLUOXETINE HCL 469 92 6 10
RISPERIDONE 449 115 7 2
CITALOPRAM HBR 351 95 8 12
LAMOTRIGINE 349 40 9 13
BUPROPION HCL SR 331 74 10 26
PAROXETINE HCL 309 58 11 24
SERTRALINE HCL 285 60 12 4
LITHIUM CARBONATE 281 50 13 17
QUETIAPINE FUMARATE 266 19 14 5
MIRTAZAPINE 226 71 15 14
VENLAFAXINE HCL ER 209 63 16 15
GABAPENTIN 204 35 17 22
BUPROPION XL 196 55 18 18
CARBAMAZEPINE 190 31 19 37
ALPRAZOLAM 142 25 20 50
CHLORPROMAZINE HCL 139 0 21 68
SEROQUEL XR 135 0 22 20
AMITRIPTYLINE HCL 132 57 R 23 42
METHYLPHENIDATE HCL 131 26 24 57
VENLAFAXINE HCL 129 53 25 44
DIVALPROEX SODIUM ER 128 0 26 6
ABILIFY 125 0 27 8
PRISTIQ ER 115 23 28 36
DEXTROAMPHETAMINE-AMPHETAMINE 102 0 S2 29 63
ESCITALOPRAM OXALATE 101 29 30 19
TOPIRAMATE 100 0 31 40
TRAMADOL HCL 90 0 32 71
SEROQUEL 87 0 33 31
DOXEPIN HCL 79 29 34 43
OLANZAPINE 77 33 35 11
ATENOLOL 76 13 36 88
TRIHEXYPHENIDYL HCL 70 24 R 37 58
ZIPRASIDONE HCL 68 0 38 29
PROMETHAZINE HCL 67 0 R 39 91
DEXTROAMPHETAMINE SULFATE 67 13 S2 39 91
CYCLOBENZAPRINE HCL 65 0 R 41 80
BENZTROPINE MESYLATE 64 0 R 42 3
SAPHRIS 61 0 43 81
OXCARBAZEPINE 61 0 43 41
LATUDA 53 0 45 47
FLUVOXAMINE MALEATE 53 0 45 55
DIVALPROEX SODIUM 52 0 47 21
PERPHENAZINE 51 17 48 45
THIORIDAZINE HCL 50 11 R 49 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.